| Product Code: ETC7635237 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market - Industry Life Cycle |
3.4 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market - Porter's Five Forces |
3.5 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.6 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.8 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about neonatal hypoxic-ischemic encephalopathy (HIE) in Ireland |
4.2.2 Technological advancements in HIE treatment options |
4.2.3 Rising incidence of neonatal HIE cases in Ireland |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of new HIE treatment therapies |
4.3.2 Limited availability of specialized healthcare facilities for neonatal HIE in Ireland |
5 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Trends |
6 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market, By Types |
6.1 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market, By Symptoms |
6.1.1 Overview and Analysis |
6.1.2 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Symptoms, 2021- 2031F |
6.1.3 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Breathing Problems, 2021- 2031F |
6.1.4 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Feeding Problems, 2021- 2031F |
6.1.5 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Missing Reflexes, 2021- 2031F |
6.1.6 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Seizures, 2021- 2031F |
6.1.7 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Low Apgar Scores, 2021- 2031F |
6.1.8 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Low or High Muscle Tone, 2021- 2031F |
6.2 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Therapeutic hypothermia, 2021- 2031F |
6.2.3 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.4 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market, By Mode of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.3 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.4 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market, By End-User |
6.5.1 Overview and Analysis |
6.5.2 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Import-Export Trade Statistics |
7.1 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Export to Major Countries |
7.2 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Imports from Major Countries |
8 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Key Performance Indicators |
8.1 Number of healthcare facilities offering specialized neonatal HIE treatment |
8.2 Adoption rate of advanced HIE treatment technologies in Ireland |
8.3 Research and development investment in novel therapies for neonatal HIE in Ireland |
9 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market - Opportunity Assessment |
9.1 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.2 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.4 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market - Competitive Landscape |
10.1 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Revenue Share, By Companies, 2024 |
10.2 Ireland Neonatal Hypoxic-Ischemic Encephalopathy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here